GSK's pivotal AZUR-1 trial of cancer immunotherapy Jemperli, as a way to delay or eliminate surgery in pre-operative rectal ...
July 13 (Reuters) - GSK said on Monday its cancer drug Jemperli met the primary goal of a mid-stage trial, with a clinically ...
Some rectal cancer patients might be spared surgery and the lifelong need for a colostomy bag if they undergo MRI screening, a new study finds. The scans might accurately predict which patients have a ...
In what GSK says represents a potential way to transform treatment for patients with certain types of rectal cancer, the ...
GSK announces positive interim results from registrational phase II AZUR-1 trial of Jemperli in dMMR/MSI-H locally advanced rectal cancer: London, UK Tuesday, July 14, 2026, 12:00 ...
A treatment for rectal cancer being developed by GSK has shown positive results in interim testing, the pharma giant ...
Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required. To avoid life-altering ...
GSK's immunotherapy drug Jemperli achieved its primary goal in a phase II trial, showing significant efficacy in treating a ...
Robotic APR shows better short-term outcomes than laparoscopic APR, with lower positive resection margins and conversion rates to open surgery. Robotic APR is associated with longer operation times ...
Dr. Andreas M. Kaiser explains how a colostomy may preserve a patient’s health and help to avoid colorectal cancer complications. Although a permanent colostomy can serve as a life-saving measure for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results